Drugs News and Research

RSS

Drug use theft among Doctors and Nurses

Western Australia’s Corruption and Crime Commission (CCC) revealed in a recent report that there has been a constant theft and abuse of restricted drugs by healthcare staff including physicians and nurses.

23 Apr 2010

Genetic tests that may replace biopsies

Genetic tests conducted on blood samples may replace the current biopsies when it comes to checking if immune systems are rejecting new organs of heart transplant patients. The test would be far less invasive and uncomfortable as compared to the biopsies, not to mention more affordable.

23 Apr 2010

FDA Advisory Committees vote against approval of Acurox NDA

Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.

23 Apr 2010

Celator Pharmaceuticals presents data on CPX-351 Liposome Injection and HDPN formulation

Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research in Washington, DC (Abstracts 3698 and 5534).

23 Apr 2010

Aragon Pharmaceuticals raises $22M through Series B financing

Aragon Pharmaceuticals Inc. today announced that it has secured $22 million in Series B financing.

23 Apr 2010

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

Ampio Pharmaceuticals, Inc., today announced that it has entered into a letter of intent to acquire DMI Biosciences, Inc.

23 Apr 2010

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Mystic Pharmaceuticals today announced it has been granted U.S. Patent 7,669,597, a key technology of its VRx2™ drug delivery platform. The VRx2™ Delivery Platform provides preservative free, precision dose delivery for ophthalmic and intranasal drugs and biologics.

22 Apr 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.

From Baxter International Inc. 22 Apr 2010

CancerDrugsDirect.com provides customers access to affordable cancer medications

When someone is diagnosed with cancer, the effects can be devastating both physically as well as financially. Recent studies have shown that many cancer patients are foregoing care because of the skyrocketing cost of cancer treatments.

22 Apr 2010

MicroStockProfit.com announces investment report featuring Cell Therapeutics

MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Apr 2010

Halo Benefits introduces new pharmacy prescription card that offers discounts to consumers

Halo Benefits, Inc., a subsidiary of Halo Companies, Inc., announced today that it now offers HaloRx, a pharmacy prescription card that offers discounts to consumers. The new discount card is offered now at a time when the cost of prescription drugs is at a record high. "We are excited about the opportunity to offer more affordable options to consumers with medication needs.

22 Apr 2010

Cancers deficient in ASS enzyme allow ADI-PEG 20 to inhibit cancer cell growth

Polaris Group scientists and university collaborators reported at the American Association for Cancer Research (AACR), that a number of different cancers have a deficiency in a specific enzyme, argininosuccinate synthetase (ASS), which allows pegylated arginine deiminase (ADI-PEG 20) to inhibit cancer cell growth.

22 Apr 2010

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

Virtify, Inc., today announced the availability of a new IDC Health Insights study titled "Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance." The new IDC Health Insights study, which was commissioned by Virtify, shows a growing trend in the life sciences industry away from traditional document management systems to emerging Enterprise Content Compliance (ECC) solutions.

22 Apr 2010

Need for better understanding potential dangers of prescription painkillers

In response to a study published in the April issue of the American Journal of Preventive Medicine called "Hospitalizations for Poisoning by Prescription Opioids, Sedatives, and Tranquilizers," the Waismann Method of Opiate Detoxification is urging Americans to take measures to better understand and recognize the potential dangers and addictive nature of prescription painkillers.

22 Apr 2010

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

22 Apr 2010

GUMC researchers awarded grant to discover and develop new smoking cessation drugs

A Georgetown University Medical Center research team has been awarded a grant from the National Institute on Drug Abuse to discover and develop new smoking cessation drugs based on an unconventional theory about nicotine addiction. Kenneth Kellar, PhD, a professor of pharmacology at GUMC is principal investigator of the five year grant totaling $4.6 million.

22 Apr 2010

Colorado Governor moves forward with implementing reforms; Nevada community health centers feel financial pinch

In Colorado, "Gov. Bill Ritter signed four bills he promised will rein in skyrocketing health care costs on Tuesday and appointed a director who will oversee 10 state agencies to implement the Obama administration's new health care plan.

22 Apr 2010

Positive results from preclinical EP-302 program presented at AACR 2010

Drug discovery and development company Esperance Pharmaceuticals today presented positive results from their preclinical EP-302 program that support the initiation of IND enabling studies. EP-302 is a targeted membrane-disrupting peptide designed to selectively kill cells that express nucleolin on their surface. Nucleolin is a protein that is over-expressed in a wide range of cancers and tumor endothelial cells.

22 Apr 2010

H1N1 flu epidemic has lessons to offer health care providers: Anesthesia Progress

The H1N1 flu epidemic has lessons to offer health care providers. The limited amount of vaccine available initially left pregnant women, small children with medical conditions, and other high-risk populations waiting in long lines. The problems encountered in reaching certain segments of the population apply to the provision of dental care as well as other disciplines.

22 Apr 2010

Research findings may help personalize use of statins, scientists say

Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered why statins -- popular drugs that lower cholesterol and appear to protect against colorectal cancer development -- work for some people, but not for all.

22 Apr 2010

Drugs News and Research

Drug use theft among Doctors and Nurses

Genetic tests that may replace biopsies

FDA Advisory Committees vote against approval of Acurox NDA

Celator Pharmaceuticals presents data on CPX-351 Liposome Injection and HDPN formulation

Aragon Pharmaceuticals raises $22M through Series B financing

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

CancerDrugsDirect.com provides customers access to affordable cancer medications

MicroStockProfit.com announces investment report featuring Cell Therapeutics

Halo Benefits introduces new pharmacy prescription card that offers discounts to consumers

Cancers deficient in ASS enzyme allow ADI-PEG 20 to inhibit cancer cell growth

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

Need for better understanding potential dangers of prescription painkillers

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

GUMC researchers awarded grant to discover and develop new smoking cessation drugs

Colorado Governor moves forward with implementing reforms; Nevada community health centers feel financial pinch

Positive results from preclinical EP-302 program presented at AACR 2010

H1N1 flu epidemic has lessons to offer health care providers: Anesthesia Progress

Research findings may help personalize use of statins, scientists say

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News